Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Health Care Fund". In its second-quarter 2026 investor letter, Baron Health Care Fund highlighted Guardant Health, Inc. (NASDAQ:GH). Guardant Health, Inc. (NASDAQ:GH) is a US based precision oncology company that provides blood and tissue tests, along with data sets. Guardant Health, Inc. (NASDAQ:GH) has a market capitalization of $21.44 billion with a 52-week trading range between $40.36 - $176.58. Baron Health Care Fund stated the following regarding Guardant Health, Inc. (NASDAQ:GH) in its Q2 2026 investor letter: